Inspire Medical Systems, Inc. (INSP) Presents at UBS Global Healthcare Conference 2025 Transcript

Core Insights - The company reported significant progress in transitioning from the Inspire IV system to the next-generation Inspire V system during the third quarter [1] - Strong patient outcomes associated with the Inspire V device were highlighted, based on a clinical study conducted in Singapore and initial commercial experiences in the United States [1] Group 1 - The third quarter was crucial for the company, marked by challenges and a focus on the transition to Inspire V [1] - The results from the third quarter demonstrated a positive pickup, indicating successful progress in the transition [1] - The outcomes from the clinical study and commercial experience with Inspire V are described as strong, setting a positive outlook for the future [1]